Related Experiment Video

Updated: Jun 4, 2026

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Cyclooxygenase-2 confers growth advantage to syngeneic pancreatic cancer cells

Hiroki Takahashi1, Aihua Li, David W Dawson

  • 1Department of Surgery, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.

Pancreas
|February 24, 2011
PubMed
Abstract

Insights

Cyclooxygenase-2 (COX-2) expression promotes pancreatic cancer cell growth and prostaglandin E2 (PGE2) production. Understanding COX-2 in pancreatic cancer (PaCa) may lead to new therapeutic strategies targeting this pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The cyclooxygenase-2 (COX-2)/prostanoid pathway is a potential therapeutic target for various cancers.
  • The specific role of COX-2 in pancreatic cancer (PaCa) pathogenesis remains incompletely understood.

Purpose of the Study:

  • To characterize the cellular phenotype of pancreatic cancer cells engineered to express cyclooxygenase-2 (COX-2).

Main Methods:

  • COX-2 or control vectors were stably introduced into COX-2-negative pancreatic cancer cells.
  • Prostaglandin E2 (PGE2) levels were quantified using liquid chromatography-tandem mass spectrometry.
  • Cell proliferation, apoptosis-related gene expression, and tumor growth in vivo were assessed.

Main Results:

  • COX-2 expression significantly enhanced both anchorage-dependent and -independent cell growth.
  • Elevated prostaglandin E2 (PGE2) production was observed in COX-2 expressing cells.
  • COX-2 expressing cells exhibited faster tumor growth in a xenograft model and altered apoptotic gene expression.

Conclusions:

  • These findings elucidate the protumorigenic effects of COX-2 in pancreatic cancer.
  • This study provides a foundation for further mechanistic investigations into the COX-2/prostanoid pathway in PaCa.
  • The results may inform the development of novel therapeutic strategies targeting COX-2 in pancreatic cancer.

More Related Videos

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...